Source: Annual Congress 2005 - Spirometry - now and in the future
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). FEF_25-75% should not yet be used to define a bronchodilator response in individuals. Eur Respir J 2005; 26: Suppl. 49, 4225

Member's Comments

No comment yet.

Related content which might interest you: Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006 Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006 Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction? Source: Eur Respir J 2006; 27: 1244-1250 Year: 2006 The role of forced partial expiratory flows to test the bronchodilator response in COPD Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Is the forced expiratory volume in 6 seconds (FEV6) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients Source: Eur Respir J 2001; 18: Suppl. 33, 13s Year: 2001 Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Lung function measurement in respiratory diseases: mechanisms Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 Why should we perform lung function tests? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace Source: Eur Respir J 2006; 27: 374-377 Year: 2006 Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag study Source: Eur Respir J 2001; 18: 770-779 Year: 2001 Sources of variation in forced expiratory volume in one second and forced vital capacity Source: Eur Respir J 2006; 27: 767-773 Year: 2006 Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years Source: Annual Congress 2013 –COPD diagnosis Year: 2013 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation Source: Annual Congress 2007 - New drugs for asthma Year: 2007 The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002